Endothelial function, oxidative stress and inflammatory studies in chronic coronary slow flow phenomenon patients

Cardiology

Volumn 121, Issue 3, 2012, Pages 197-203

  Kopetz, Victoria ^a   Kennedy, Jennifer ^a   Heresztyn, Tamila ^a   Stafford, Irene ^a   Willoughby, Scott R ^b   Beltrame, John F ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Coronary slow flow; Endothelial function; Microvascular dysfunction; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; GLYCERYL TRINITRATE; HOMOCYSTEINE; MALONALDEHYDE; MYELOPEROXIDASE; N(G),N(G) DIMETHYLARGININE; SALBUTAMOL;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SLOW FLOW PHENOMENON; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; ALBUTEROL; BIOLOGICAL MARKERS; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NITROGLYCERIN; NO-REFLOW PHENOMENON; OXIDATIVE STRESS; PROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 84859650775     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000336948     Document Type: Article

References (30)

1. Beltrame JF, Limaye SB, Horowitz JD: The coronary slow flow phenomenon - A new coronary microvascular disorder. Cardiology 2002; 97: 197-202.
2. Mosseri M, Yarom R, Gotsman MS, Hasin Y: Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-972. (Pubitemid 17174942)
3. Mangieri E, Macchiarelli G, Ciavolella M, et al: Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-381. (Pubitemid 26100780)
4. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD: Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J 2003; 146: 84-90. (Pubitemid 36851304)
5. Sezgin AT, Sigirci A, Barutcu I, et al: Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003; 14: 155-161. (Pubitemid 36543418)
6. Turhan H, Saydam GS, Erbay AR, et al: Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol 2006; 108: 224-230. (Pubitemid 43330618)
7. Barutcu I, Sezgin AT, Sezgin N, et al: Elevated plasma homocysteine level in slow coronary flow. Int J Cardiol 2005; 101: 143-145. (Pubitemid 40614751)
8. Shirani S, Darabian S, Jozaghi S, Hamidian R: Correlation between endothelial dysfunction in normal coronary patients with slow flow and aortic ectasia: The first report. Cardiol J 2009; 16: 146-150.
9. Wilkinson IB, Hall IR, MacCallum H, et al: Pulse-wave analysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-152. (Pubitemid 34076246)
10. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP: An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993; 14: 160-167. (Pubitemid 23089501)
11. Tewari PC, Zhang B, Bluestein BI: Analytical and clinical evaluation of the Bayer ADVIA Centaur homocysteine assay. Clin Chim Acta 2004; 342: 171-178. (Pubitemid 38352926)
12. Marie Dupuy A, Boutet A, Paul Cristol J: Evaluation of the high-sensitivity, full-range Olympus CRP OSR6199 application on the Olympus AU640. Clin Chem Lab Med 2007; 45: 402-406. (Pubitemid 46480891)
13. Heresztyn T, Worthley MI, Horowitz JD: Determination of l-Arginine and NG, NG -And NG, NG' -dimethyl-L-Arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 805: 325-329. (Pubitemid 38596755)
14. Arstall MA, Yang J, Stafford I, Betts WH, Horowitz JD: N-Acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995; 92: 2855-2862.
15. Evrengul H, Tanriverdi H, Kuru O, et al: Elevated homocysteine levels in patients with slow coronary flow: Relationship with Helicobacter pylori infection. Helicobacter 2007; 12: 298-305. (Pubitemid 47196331)
16. Tanriverdi H, Evrengul H, Enli Y, et al: Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Cardiology 2007; 107: 313-320. (Pubitemid 46788250)
17. Riza Erbay A, Turhan H, Yasar AS, et al: Elevated level of plasma homocysteine in patients with slow coronary flow. Int J Cardiol 2005; 102: 419-423. (Pubitemid 40956902)
18. Li JJ, Qin XW, Li ZC, et al: Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 2007; 385: 43-47.
19. Yazici M, Aksakal E, Demircan S, Sahin M, Sagkan O: Is slow coronary flow related with inflammation and procoagulant state? (article in Turkish). Anadolu Kardiyol Derg 2005; 5: 3-7. (Pubitemid 40372609)
20. Kopetz VA, Penno MA, Hoffmann P, Wilson DP, Beltrame JF: Potential mechanisms of the acute coronary syndrome presentation in patients with the coronary slow flow phenomenon - Insight from a plasma proteomic approach. Int J Cardiol 2011;5:84-91.
21. Selcuk MT, Selcuk H, Temizhan A, et al: Asymmetric dimethylarginine plasma concentrations and L-Arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow. Coron Artery Dis 2007; 18: 545-551. (Pubitemid 47556386)
22. Bae SW, Stuhlinger MC, Yoo HS, et al: Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 2005; 95: 729-733. (Pubitemid 40332650)
23. Cao Y, Yang K, Zhang Z, Ouyang M, Xiao L: Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010; 35: 301-306.
24. Shimokawa H: Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch 2010; 459: 915-922.
25. Liu Y, Bubolz AH, Mendoza S, Zhang DX, Gutterman DD: H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ Res 2011; 108: 566-573.
26. Larkin SW, Clarke JG, Keogh BE, et al: Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 1989; 64: 956-958. (Pubitemid 19246180)
27. Godfraind T: Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 1993; 110: 1201-1205. (Pubitemid 24005261)
28. Pekdemir H, Polat G, Cin VG, et al: Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol 2004; 97: 35-41. (Pubitemid 39178521)
29. Sen N, Basar N, Maden O, et al: Increased mean platelet volume in patients with slow coronary flow. Platelets 2009; 20: 23-28.
30. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD: The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol. 2004; 44: 57-62. (Pubitemid 38968457)